PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?
about
Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumoursHistone demethylase lysine demethylase 5B in development and cancerHistone H3K4 demethylases are essential in development and differentiationHistone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genesErasing the methyl mark: histone demethylases at the center of cellular differentiation and diseaseNovel gene expression patterns along the proximo-distal axis of the mouse embryo before gastrulation.Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiationInterference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.Chromatin and oxygen sensing in the context of JmjC histone demethylasesPhysical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complexHypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylaseMolecular pathways involved in pregnancy-induced prevention against breast cancer.MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistanceEpigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer.Crystallization and preliminary crystallographic analysis of a PHD domain of human JARID1BImpairment of preimplantation porcine embryo development by histone demethylase KDM5B knockdown through disturbance of bivalent H3K4me3-H3K27me3 modifications.Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.Jarid1b targets genes regulating development and is involved in neural differentiationAn evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448Functional analysis of the transcription repressor PLU-1/JARID1B.Escape from Mitotic Arrest: An Unexpected Connection Between Microtubule Dynamics and Epigenetic Regulation of Centromeric Chromatin in Schizosaccharomyces pombe.Histone demethylases and cancer.Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.New cancer targets emerging from studies of the Von Hippel-Lindau tumor suppressor protein.Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma.The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.Chromatin as an oxygen sensor and active player in the hypoxia response.Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenasesRole of H3K4 demethylases in complex neurodevelopmental diseases.Histone lysine demethylases as targets for anticancer therapy.Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.Histone modifying enzymes: novel disease biomarkers and assay development.
P2860
Q24298477-7979DADA-08AE-4B71-99E8-74904209FF81Q24647085-9A6605B2-533C-4253-9CBF-B019D0473E20Q28076257-0C5B9D49-E077-4203-94AF-C767019C785DQ28241709-1D55B3C7-096C-4337-B5C1-5B799FFA5857Q28511595-ED0EEA53-0D23-4305-9904-F1AB4E099459Q29617086-830F98DB-1040-483E-B5F2-9F2179EC2281Q30359895-6AB2CB7F-BD38-4831-9050-AB8D3A4A6E37Q30668581-E37568B1-7FC4-4D83-85B6-E12DDA77FD47Q30986201-C94DF603-1DD9-45C2-AE0F-DEDCAAA0DD99Q33195347-D95E19BC-B63E-434A-8669-9205FB33069BQ33557525-E4CA705E-D9C7-4164-B448-D699DB049525Q33977987-272C6090-FBFB-4F13-9451-C1C09FECB525Q34090323-6D615964-6D1E-45E3-BC6D-F858B789244FQ34103385-D6A6E2C0-8F40-40B8-9ACC-64673265F498Q34355649-288D8EC3-DF76-4C11-8EB0-4394F4CC7215Q34430188-8BE5702F-F054-44AF-B7A6-B24C24F7F903Q34668630-D79F7068-F488-4D12-9778-F54434DDA0D8Q34756694-832A0BFD-948F-4537-9BE3-640DC676C406Q34897761-25D75BFC-D4D2-4311-BE58-EC39A61760C0Q35150331-CE63FA24-526F-4ABA-8FA3-7BA2FD098044Q35201323-1BADA9AB-09F7-4CEF-98BF-20526E2BBB27Q35562595-F48B9855-DD7C-4A44-8FEC-503F467F1231Q35596871-1170F47C-230F-4DEA-AEAA-FA1B1A31C4B0Q35626323-CA6659B3-A907-4FFA-B51D-C7EE07A4DB41Q35769842-7203BDEB-7D8A-49D3-8EE7-40A298C2AFEBQ35936553-DF0B97F3-8201-46F6-B863-4D8F6216CBCAQ36315263-AAC61A43-9065-4F42-9D45-102B47F94814Q36365254-7494F1AD-6079-448D-8D5B-A05560144465Q36421138-55BE7982-302E-4615-85C0-62F37B444F69Q36594686-02AAF5FD-2A9F-49D5-980B-B9ADD1C12F34Q36616276-840C974D-23F2-4C1D-95AF-64E6E8CEBE0EQ36668449-8208A9B8-7156-4D06-9F78-94DFAA6C9CA0Q37330856-B7E71284-1224-4D92-BDBC-32A821A017AAQ37706322-8CD9A4CA-30F0-4864-BCBE-A8E0A5442B06Q37933611-32365F1E-4A7E-4164-9A1C-0E900FBFDEF7Q37957006-C46E0639-36CF-4279-A403-3265833CEC44Q37961732-6DDCD0B0-DD58-4777-87C1-C52429A9ED8DQ38162717-2D3BA2EF-CC00-4FFF-862C-F6EFC6C94C1BQ38459037-DCA41117-C370-49F8-A7B9-1EEB940E7721Q38691865-DEE4D9E9-E14B-4515-95E9-1FC6F6B9C6E2
P2860
PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@ast
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@en
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@nl
type
label
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@ast
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@en
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@nl
prefLabel
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@ast
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@en
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@nl
P2093
P2860
P356
P1476
PLU-1 nuclear protein, which i ...... : a new cancer/testis antigen?
@en
P2093
Angelo G Scibetta
Bente Madsen
John Copier
Joyce Taylor-Papadimitriou
Lucienne Cooper
Pei Juan Lu
P2860
P304
P356
10.1002/IJC.10644
P577
2002-10-01T00:00:00Z